Profile data is unavailable for this security.
About the company
Lumos Diagnostics Holdings Limited is an Australia-based company specializes in point-of-care (POC) diagnostic test technology to help healthcare professionals diagnose and manage medical conditions. The Company offers customized assay development and manufacturing services for POC tests and digital reader platforms. It also directly develops, manufactures, and commercializes, Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections and ViraDx, a three-in-one POC test for influenza A, influenza B and COVID-19. Its services include assay development, reader development, cloud and data, and manufacturing. It manages the full development program for POC assays.
- Revenue in AUD (TTM)17.25m
- Net income in AUD-13.32m
- Incorporated2018
- Employees--
- LocationLumos Diagnostics Holdings Ltd100 Albert Rd, Level 4SOUTH MELBOURNE 3205AustraliaAUS
- Phone+61 39087-1598
- Websitehttps://lumosdiagnostics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Atomo Diagnostics Ltd | 4.24m | -6.85m | 13.42m | -- | -- | 1.33 | -- | 3.17 | -0.0108 | -0.0108 | 0.0067 | 0.0158 | 0.3044 | 1.25 | 3.09 | -- | -49.17 | -31.42 | -54.41 | -34.20 | 41.48 | 42.58 | -161.56 | -120.99 | 4.84 | -- | 0.0083 | -- | 66.63 | 51.01 | 31.23 | -- | -54.38 | -- |
| Control Bionics Ltd | 5.97m | -5.91m | 16.34m | -- | -- | 2.10 | -- | 2.74 | -0.0381 | -0.0381 | 0.0374 | 0.0315 | 0.6732 | 2.41 | 2.98 | -- | -66.73 | -41.07 | -85.40 | -45.97 | 75.62 | 68.78 | -99.13 | -92.33 | 1.40 | -112.62 | 0.133 | -- | 2.08 | 46.24 | -5.02 | -- | 67.72 | -- |
| Resonance Health Ltd | 8.80m | 169.31k | 17.47m | 18.00 | 111.76 | 1.55 | 26.17 | 1.98 | 0.0003 | 0.0003 | 0.0188 | 0.0245 | 0.5631 | -- | 5.08 | -- | 1.08 | -3.19 | 1.40 | -3.56 | -- | -- | 1.92 | -7.63 | -- | -- | 0.2527 | -- | 95.15 | 19.18 | 121.70 | -33.17 | 1.63 | -- |
| Singular Health Group Ltd | 945.75k | -2.88m | 18.82m | -- | -- | 12.35 | -- | 19.89 | -0.018 | -0.0308 | 0.0063 | 0.0074 | 0.3536 | 8.73 | 22.14 | -- | -107.62 | -- | -331.71 | -- | 124.56 | -- | -304.36 | -- | 2.42 | -- | 0.1316 | -- | 112.26 | -- | 42.12 | -- | -- | -- |
| ImExHS Ltd | 24.68m | -3.42m | 19.05m | 400.00 | -- | 1.26 | -- | 0.7718 | -0.0794 | -0.0794 | 0.5713 | 0.3314 | 1.10 | 97.11 | 3.78 | 61,692.52 | -15.28 | -22.17 | -20.83 | -29.21 | 31.95 | 29.75 | -13.85 | -31.20 | 1.53 | -4.58 | 0.0593 | -- | 14.79 | 26.48 | -37.97 | -- | 5.61 | -- |
| Lumos Diagnostics Holdings Ltd | 17.25m | -13.32m | 23.86m | -- | -- | 1.49 | -- | 1.38 | -0.0276 | -0.0276 | 0.035 | 0.0215 | 0.426 | 4.37 | 7.02 | -- | -32.88 | -40.29 | -54.62 | -58.07 | 63.77 | 49.44 | -77.19 | -151.15 | 0.6949 | -6.01 | 0.5314 | -- | 5.66 | 19.53 | 4.22 | -- | -47.99 | -- |
| Cleanspace Holdings Ltd | 15.72m | -3.13m | 28.74m | -- | -- | 1.50 | -- | 1.83 | -0.0405 | -0.0405 | 0.2036 | 0.2469 | 0.5714 | 1.49 | 4.45 | -- | -11.37 | -3.31 | -13.04 | -4.14 | 72.25 | 74.42 | -19.89 | -4.38 | 3.92 | -- | 0.1528 | -- | 30.01 | 7.29 | 61.54 | -- | -20.61 | -- |
| Nova Eye Medical Ltd | 23.45m | -8.79m | 35.50m | 130.00 | -- | 1.66 | -- | 1.51 | -0.0436 | -0.0436 | 0.1149 | 0.0932 | 0.7785 | 0.7744 | 7.44 | -- | -29.18 | -15.92 | -36.41 | -18.97 | 86.64 | 83.45 | -37.49 | -57.51 | 1.84 | -19.35 | 0.1357 | -- | 36.90 | 7.54 | 42.52 | -- | -18.46 | -- |
| Universal Biosensors, Inc. | 7.08m | -12.39m | 35.77m | 97.00 | -- | 1.71 | -- | 5.05 | -0.0498 | -0.0498 | 0.0285 | 0.0701 | 0.2301 | 0.6592 | 4.25 | -- | -40.27 | -21.79 | -48.77 | -27.14 | 56.95 | 46.16 | -175.04 | -209.31 | 3.75 | -- | 0.0023 | -- | 46.58 | -37.48 | 74.90 | -- | 26.83 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Perennial Value Management Ltd.as of 12 Sep 2024 | 66.19m | 8.88% |
